Stefano Ferrara
About Stefano Ferrara
Stefano Ferrara is the Director of Clinical Science at BeiGene in Basel, Switzerland, with a comprehensive background in oncology research and clinical trial management.
Company
Stefano Ferrara currently holds the position of Director, Clinical Science at BeiGene in Basel, Switzerland. His role involves leading clinical science initiatives and strategic global clinical approaches within the company.
Previous Roles
Stefano Ferrara has accumulated extensive experience in clinical science and research through various roles. Notably, he served as Senior Medical Director at SOTIO a.s. from 2020 to 2021 in Basel Area, Switzerland. Prior to that, he spent nine years at Celgene in Neuchatel, holding multiple positions including Director Program Lead Scientist, Principal Clinical Research Scientist, and Senior Clinical Research Scientist. Additionally, he worked at Novartis as Clinical Trial Head from 2007 to 2011, and as Medical Manager at Sanofi - Aventis SpA from 2005 to 2007.
Education and Expertise
Stefano Ferrara studied Pharmacology at Università degli Studi di Milano, achieving a Master's degree from 1999 to 2002. He also graduated in Pharmacy from the same institution. His expertise spans across key areas including GI, Lung, GU, and Pediatric cancers, with a strong proficiency in medical data analysis, clinical and technical writing, and leading the creation of pivotal clinical documents.
Achievements
Stefano Ferrara spearheaded a Phase III study in Mantle Cell Lymphoma, highlighting his commitment to advancing oncology research. He has established direct collaborations with Key Opinion Leaders globally across Phase I through Phase III studies and has played an instrumental role in building and guiding R&D teams while ensuring strict regulatory adherence.
Scientific Publications
Stefano Ferrara has an extensive portfolio of scientific publications, demonstrating his dedication to advancing clinical research and elevating patient care. His work is recognized within the scientific community, underscoring his contributions to oncology and other specialized medical fields.